Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Sara Lodi, Martin Fisher, Andrew Phillips, Andrea De Luca, Jade Ghosn, Ruslan Malyuta, Robert Zangerle, Santiago Moreno, Philippe Vanhems, Faroudy Boufassa, Marguerite Guiguet, Kholoud Porter

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
Original languageEnglish
Pages (from-to)e78642-e78642
JournalPLoS One
Volume8
DOIs
Publication statusPublished - 2013

Keywords

  • CD4
  • drugs
  • hiv
  • markers

Fingerprint

Dive into the research topics of 'Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection'. Together they form a unique fingerprint.

Cite this